Rhenman & Partners Asset Management AB

Holdings History for SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN)

Symbol: SUPN on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2017		-0.19%	$0	0	-30,000	-100%	$51.30	Q3 2017
30 Jun 2017	0.19%	-1.2%	$1,293,000	30,000	-200,000	-87%	$43.10	Q2 2017
31 Mar 2017	1.1%	-0.1%	$7,199,000	230,000	-20,000	-8%	$31.30	Q1 2017
31 Dec 2016	1.2%	-0.1%	$6,313,000	250,000	-20,000	-7.4%	$25.25	Q4 2016
30 Sep 2016	1.1%	-0.04%	$6,677,100	270,000	-10,000	-3.6%	$24.73	Q3 2016
30 Jun 2016	1%	+0.04%	$5,704,000	280,000	+10,000	+3.7%	$20.37	Q2 2016
31 Mar 2016	0.82%	-0.05%	$4,118,000	270,000	-18,000	-6.2%	$15.25	Q1 2016
31 Dec 2015	0.59%	-0.13%	$3,871,000	288,000	-65,328	-18%	$13.44	Q4 2015
30 Sep 2015	0.79%	-0.14%	$4,957,000	353,328	-63,672	-15%	$14.03	Q3 2015
30 Jun 2015	1%	-0.08%	$7,081,000	417,000	-33,800	-7.5%	$16.98	Q2 2015
31 Mar 2015	0.97%	+0.43%	$5,450,000	450,800	+200,000	+80%	$12.09	Q1 2015
31 Dec 2014	0.62%	+0.1%	$2,082,000	250,800	+38,800	+18%	$8.30	Q4 2014
30 Sep 2014	0.57%	-0.04%	$1,842,000	212,000	-15,000	-6.6%	$8.69	Q3 2014
30 Jun 2014	0.74%	+0.1%	$2,486,000	227,000	+30,463	+15%	$10.95	Q2 2014
31 Mar 2014	0.59%	-0.08%	$1,757,000	196,537	-28,463	-13%	$8.94	Q1 2014
31 Dec 2013	0.68%	0%	$1,697,000	225,000	0		$7.54	Q4 2013

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.